| Publication Date | Title | Author(s) |
| Apr-2021 | COVID-19 living evidence synthesis #6 (version 6.2): What is the efficacy and effectiveness of available COVID-19 vaccines in general and specifically for variants of concern? | Iorio, A; Little, J; Linkins, L; Abdelkader, W; Bennett, D; Lavis, JN |
| Sep-2021 | COVID-19 living evidence synthesis #6 (version 6.20): What is the efficacy and effectiveness of available COVID-19 vaccines in general and specifically for variants of concern? | Iorio, A; Little, J; Linkins, L; Abdelkader, W; Bennett, D; Lavis, JN |
| Oct-2021 | COVID-19 living evidence synthesis #6 (version 6.21): What is the efficacy and effectiveness of available COVID-19 vaccines in general and specifically for variants of concern? | Iorio, A; Little, J; Linkins, L; Abdelkader, W; Bennett, D; Lavis, JN |
| Oct-2021 | COVID-19 living evidence synthesis #6 (version 6.22): What is the efficacy and effectiveness of available COVID-19 vaccines in general and specifically for variants of concern? | Iorio, A; Little, J; Linkins, L; Abdelkader, W; Bennett, D; Lavis, JN |
| Nov-2021 | COVID-19 living evidence synthesis #6 (version 6.23): What is the efficacy and effectiveness of available COVID-19 vaccines in general and specifically for variants of concern? | Iorio, A; Little, J; Linkins, L; Abdelkader, W; Bennett, D; Lavis, JN |
| Nov-2021 | COVID-19 living evidence synthesis #6 (version 6.24): What is the efficacy and effectiveness of available COVID-19 vaccines in general and specifically for variants of concern? | Iorio, A; Little, J; Linkins, L; Abdelkader, W; Bennett, D; Lavis, JN |
| Dec-2021 | COVID-19 living evidence synthesis #6 (version 6.25): What is the efficacy and effectiveness of available COVID-19 vaccines in general and specifically for variants of concern? | Iorio, A; Little, J; Linkins, L; Abdelkader, W; Bennett, D; Lavis, JN |
| Dec-2021 | COVID-19 living evidence synthesis #6 (version 6.26): What is the efficacy and effectiveness of available COVID-19 vaccines in general and specifically for variants of concern? | Iorio, A; Little, J; Linkins, L; Abdelkader, W; Bennett, D; Lavis, JN |
| Jan-2022 | COVID-19 living evidence synthesis #6 (version 6.27): What is the efficacy and effectiveness of available COVID-19 vaccines in general and specifically for variants of concern? | Iorio, A; Little, J; Linkins, L; Abdelkader, W; Bennett, D; Lavis, JN |
| Jan-2022 | COVID-19 living evidence synthesis #6 (version 6.28): What is the efficacy and effectiveness of available COVID-19 vaccines in general and specifically for variants of concern? | Iorio, A; Little, J; Linkins, L; Abdelkader, W; Bennett, D; Lavis, JN |
| Feb-2022 | COVID-19 living evidence synthesis #6 (version 6.29): What is the efficacy and effectiveness of available COVID-19 vaccines in general and specifically for variants of concern? | Iorio, A; Little, J; Linkins, L; Abdelkader, W; Bennett, D; Lavis, JN |
| Apr-2021 | COVID-19 living evidence synthesis #6 (version 6.3): What is the efficacy and effectiveness of available COVID-19 vaccines in general and specifically for variants of concern? | Iorio, A; Little, J; Linkins, L; Abdelkader, W; Bennett, D; Lavis, JN |
| Feb-2022 | COVID-19 living evidence synthesis #6 (version 6.30): What is the efficacy and effectiveness of available COVID-19 vaccines in general and specifically for variants of concern? | Iorio, A; Little, J; Linkins, L; Abdelkader, W; Bennett, D; Lavis, JN |
| Mar-2022 | COVID-19 living evidence synthesis #6 (version 6.33): What is the efficacy and effectiveness of available COVID-19 vaccines in general and specifically for variants of concern? | Iorio, A; Little, J; Linkins, L; Abdelkader, W; Bennett, D; Lavis, JN |
